The use of hyperimmune serum for severe influenza infections*

Critical Care Medicine

Volumn 40, Issue 3, 2012, Pages 973-975

  Rockman, Steven ^a   Maher, Darryl ^a   Middleton, Deborah ^b  

^a CSL LIMITED   (Australia)

^b CSIRO   (Australia)

Author keywords

antibody; hyperimmune; immunotherapy; influenza; passive; plasma; serum

Indexed keywords

HYPERIMMUNE GLOBULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; FERRET; INFLUENZA A (H5N1); MORBIDITY; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM; SEROCONVERSION; SURVIVAL; VIRUS INDUCTION; WEIGHT REDUCTION;

ANIMALS; FERRETS; IMMUNE SERA; INFLUENZA A VIRUS, H5N1 SUBTYPE; ORTHOMYXOVIRIDAE INFECTIONS; SEVERITY OF ILLNESS INDEX;

EID: 84857654141     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318236f486     Document Type: Article

References (11)

1. World Health Organization: Influenza (seasonal) fact sheet. Available at: http://www.who.int/mediacentre/factsheets/fs211/en/index.html. Accessed October 3, 2011
2. Morgan OW, Bramley A, Fowlkes A, et al: Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A (H1N1) disease. PLoS One 2010;5:e9694
3. Lapinsky SE: H1N1 novel influenza A in pregnant and immunocompromised patients. Crit Care Med 2010;38(Suppl 4): e52-e57
4. Luke TC, Casadevall A, et al: Hark back: Passive immunotherapy for influenza and other serious infections. Crit Care Med 2010;38(Suppl 4): e66-e73
5. Luke TC, Kilbane EM, Jackson JL, et al: Metaanalysis: Convalescent blood products for Spanish influenza pneumonia: A future H5N1 treatment? Ann Intern Med 2006;145:599-609
6. Kong LK, Zhou BP: Successful treatment of avian influenza with convalescent plasma. Hong Kong Med J 2006;12:489
7. Zhou B, Zhong N, Guan Y, et al: Treatment with convalescent plasma for influenza A (H5N1) infection. N Engl J Med 2007;357:1450-1451
8. Hung IF, To KK, Lee CK, et al: Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clin Infect Dis 2011;52:447-56
9. Smith H, Sweet C: Lessons for human influenza from pathogenicity studies with ferrets. Rev Infect Dis 1988;10:56-75
10. van Riel D, Munster VJ, de Wit E, et al: Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am J Pathol 2007;171:1215-1223
11. Middleton D, Rockman S, Pearse M, et al: Evaluation of vaccines for H5N1 influenza virus in ferrets reveals the potential for protective single-shot immunization. J Virol 2009;83:7770-7778